ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHEUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTR01

Modeling and Characterizing the Genomic Consequences of MED12 Mutations in Uterine Fibroids

Active
Institution
NORTHWESTERN UNIVERSITY AT CHICAGO, IL
Principal investigator
Mazhar Adli
Funding
$688K
Duration
2025–2030
Open portfolio

Moonbase score

Still being scored

Abstract

ABSTRACT Uterine fibroids (leiomyomas) are the most widely observed tumors in women. By age 50, more than ~70% of white and more than 80% of black women develop at least one UF tumor. Although non-malignant, they disrupt normal uterine function and cause severe health problems ~25% of reproductive-age women. The most common subtype, representing ~70% of all fibroids, is caused by recurrent somatic mutations in the MED12 gene that encodes the mediator of transcription subunit 12 (MED12) protein. The lack of proper model systems hampered our mechanistic understanding of UF development and identifying effective treatment strategies. Our long-term goal is to interrogate the functional role of driver genetic mutations in fibroid tumors and identify potential targetable mechanisms downstream of these mutations. Our objective in this proposal, a critical step toward our long-term goal, is to create and exploit disease-relevant human cellular models of UF by CRISPR engineering specific MED12 mutations, decipher their functional role in driving UF tumorigenesis and identify druggable mechanisms to target mutant cells selectively.

LOADING MOONBASE SCORE

R01EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTIntegrative and Clinical Endocrinology and Reproduction Study Section[ICER]womenfibroidsuterinemutationsfunctional rolemutant cellsfibroidnon-malignant

Questions for NORTHWESTERN UNIVERSITY AT CHICAGO

Answered by the team behind this research.

No questions yet. Sign in to ask the first one

Related grants

Same researchers, same institution, same topic, scored first.